Conditional relative survival in primary central nervous system lymphoma: a population-based study in the Netherlands

Eitemau Tebyg

• Primary therapy and survival in patients over 70 years old with primary central nervous system lymphoma: a contemporary, nationwide, population-based study in the Netherlands
  gan: van der Meulen, Matthijs, et al.
  Cyhoeddwyd: (2020)
• The Role of Rituximab in Primary Central Nervous System Lymphoma
  gan: Bromberg, Jacoline E. C., et al.
  Cyhoeddwyd: (2020)
• MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma
  gan: van der Meulen, Matthijs, et al.
  Cyhoeddwyd: (2021)
• OS10.3 Primary therapy and survival in over 70-year-old patients with primary central nervous system lymphoma: a contemporary, nationwide, population-based study in the Netherlands
  gan: van der Meulen, M, et al.
  Cyhoeddwyd: (2019)
• Treatment and Survival of Patients With Primary Effusion Lymphoma in the Netherlands: A Population-based Analysis, 2002–2015
  gan: Dinmohamed, Avinash G., et al.
  Cyhoeddwyd: (2018)